RND ETF: What Is It? A Complete Guide to Returns, Expense Ratio, Holdings, and Alternative ETFs
The First Trust Bloomberg R&D Leaders ETF tracks an index that selects companies expanding their research and development investment. The RND ETF is well suited to investors weighing its long-term outlook, with a focus on its growth stock tilt, its lack of distribution history, and its related holdings.
What Is the First Trust Bloomberg R&D Leaders ETF?
The RND ETF is designed to track the performance of the Bloomberg R&D Leaders Select Index. The index selects its constituents from a parent index of large US companies, reflecting growth in R&D spending and R&D intensity relative to revenue.
It suits long-term investors who want rules-based diversification across large US companies that treat R&D investment as a growth driver.
It is a passive (index-tracking) ETF managed by First Trust Advisors.
How Does the First Trust Bloomberg R&D Leaders ETF Invest?
| Item | Details |
|---|---|
| Tracked index | Bloomberg R&D Leaders Select Index |
| Management style | Passive (index-tracking) |
| Rebalancing frequency | Regular rebalancing and reconstitution |
| Dividend frequency | No distribution history |
| Total expense ratio | 0.60% |
The RND ETF holds mainly the index constituents, giving exposure to companies that turn R&D spending into growth investment. Because it follows index rules, the predefined selection criteria and holding structure may influence performance more than the outlook for any individual stock.
- Stock selection that reflects growth in R&D spending and its intensity
- Rules-based index tracking with regular constituent adjustments
First Trust Bloomberg R&D Leaders ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $9.7M, and the expense ratio is 0.60% per year.
The RND ETF may trade in a relatively limited market environment, so it is wise to check the bid-ask spread and trading volume when placing orders. When deciding whether to hold for the long term, it is worth comparing the fee burden together with the fund's index-tracking characteristics.
First Trust Bloomberg R&D Leaders ETF Performance and Trends
Performance may be sensitive to share price changes in large growth companies that keep investing in R&D. When information technology and growth-oriented companies lead the market, the fund may benefit relatively, but volatility can rise when expectations fade.
The R&D theme is affected by technological change and corporate willingness to invest, so it may move differently from broad market indexes. When assessing fund flows, check not only theme popularity but also trading conditions, the concentration of the sectors held, and the gap between market price and net asset value.
First Trust Bloomberg R&D Leaders ETF Pros and Cons
The fund is distinguished by its rules-based, R&D-focused selection, but investors must also accept the movements of growth stocks and specific sectors, as well as the trading conditions.
💪 Key Strengths
⚠️ Points to Watch
First Trust Bloomberg R&D Leaders ETF Alternative ETFs and Related Products
The FNDX ETF and PRF ETF shown in the table offer broad US equity exposure based on fundamental indexes, while the FNDA ETF differs in its focus on small caps. The JHMM ETF and RECS ETF differ in that they follow a multifactor mid-cap strategy and an enhanced-research core strategy, respectively, so you can compare them with the RND ETF's R&D-based selection method, fees, and distribution policy. Among its holdings, the movements of large names such as MSFT, NVDA, AMZN, AAPL, GOOGL, META, AVGO, AMGN, LLY, and APH can affect its net asset value.
| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
| Schwab Fundamental U.S. Large Company ETF | $33.03 | +0.8% | $28.6B | 0.25% | 1.43% | +22.9% | |
| Invesco RAFI US 1000 ETF | $56.79 | +0.8% | $10.1B | 0.34% | 1.3% | +22.8% | |
| Schwab Fundamental U.S. Small Company ETF | $36.58 | +0.6% | $9.0B | 0.25% | 1.21% | +18.1% | |
| John Hancock Multifactor Mid Cap ETF | $74.76 | +0.9% | $6.2B | 0.41% | 0.88% | +14.9% | |
| Columbia Research Enhanced Core ETF | $44.86 | +1.2% | $6.1B | 0.15% | 0.72% | +9.6% |
| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| GOOG | Alphabet Inc | 0.08% | $290.63 | +2.0% | $3.57T | 15.2 | 0.3% |
| NVDA | NVIDIA Corp | 0.16% | $173.73 | +2.9% | $4.19T | 22.0 | 0.45% |
| AAPL | Apple Inc | 0.16% | $355.63 | +2.0% | $5.17T | 39.6 | 0.32% |
| GOOGL | Alphabet Inc | 0.08% | $293.45 | +2.1% | $3.57T | 15.3 | 0.3% |
| AMZN | Amazon.com Inc | 0.16% | $266.17 | -1.7% | $2.88T | 21.5 | - |
| MSFT | Microsoft Corp | 0.14% | $521.12 | -2.3% | $3.87T | 27.2 | 0.74% |
First Trust Bloomberg R&D Leaders ETF Investor Checkpoints
Before investing in the RND ETF, first check whether its R&D selection criteria match your investment goals, and how the concentration in large growth stocks and the information technology sector may affect your overall portfolio. It is also important to check bid-ask prices and liquidity before trading.
| Checkpoint | What to Check | Current Status |
|---|---|---|
| Fee burden | Check how costs may affect cumulative returns over a long holding period | Check product information |
| Trading conditions | Review bid-ask spreads, trading volume, and the gap between market price and net asset value | Check needed |
| Concentration | Check how the weighting of growth and information technology holdings affects your portfolio | Strong growth stock influence |
| Distribution policy | Review how well the lack of distribution history fits your cash flow needs | No distribution history |
Companies that spend actively on R&D do not always deliver superior investment results. The value of the holdings can vary widely depending on changes in growth expectations, technological competition, the regulatory environment, and the economic cycle, and concentration in specific sectors can amplify volatility in a downturn.
The RND ETF is a passive product that investors seeking large US company exposure reflecting R&D investment characteristics may consider. However, its selection criteria and concentration differ from those of broad equity ETFs, so it is advisable to review its lack of distribution history, trading conditions, and fee burden before deciding its role in your portfolio.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of August 18, 2026.